Researcher Profile

Researcher Profile

Harold Harvey, MD

Harold Harvey, MD

Professor, Department of Medicine
Division of Hematology and Oncology
Disease Teams:
Breast Cancer
Sarcoma Cancer
hah1@psu.edu

Research Interests

  • Breast Neoplasms
  • Therapeutics
  • Neoplasms
  • Aminoglutethimide
  • Drug Therapy
  • Estrogens
  • Neoplasm Metastasis
  • Tamoxifen
  • Bone and Bones
  • Prostatic Neoplasms
  • Aromatase Inhibitors
  • Hydrocortisone

Clinical Trials

A Phase II Study of REGN2810, a Fully Human Monoclonal Antibody to Programmed Death-1, in Patients with Advanced Basal Cell Carcinoma who Experienced Progression of Disease on Hedgehog Pathway Inhibitor Therapy or were Intolerant of Prior Hedgehog Pathway Inhibitor Therapy
A Randomized Phase III Double Blinded Placebo Controlled Trial of Aspirin as Adjuvant Therapy for HER2 Negative Breast Cancer: THE ABC Trial
A Phase III Multi-center, Randomized, Open-label Trial to Evaluate Efficacy and Safety of Ribociclib With Endocrine Therapy as an Adjuvant Treatment in Patients With Hormone Receptor-positive, HER2-negartive Early Breast Cancer
Predicting Breast Cancer Metastasis: Signaling Pathway Biomarker Identification Using Reverse Phase Protein Microarray (RPMA) Technology

Recent Publications

2018

Cheng, Y, Ren, X, Yuan, Y, Shan, Y, Li, L, Chen, X, Zhang, L, Takahashi, Y, Yang, JW, Han, B, Liao, J, Li, Y, Harvey, H, Ryazanov, A, Robertson, GP, Wan, G, Liu, D, Chen, AF, Tao, Y & Yang, JM 2018, 'Correction to: eEF-2 kinase is a critical regulator of Warburg effect through controlling PP2A-A synthesis (Oncogene, (2016), 35, 49, (6293-6308), 10.1038/onc.2016.166)', Oncogene, vol. 37, no. 33, pp. 4633-4634. https://doi.org/10.1038/s41388-018-0322-0

2017

Somlo, G, Frankel, PH, Arun, BK, Ma, CX, Garcia, AA, Cigler, T, Cream, L, Harvey, H, Sparano, JA, Nanda, R, Chew, HK, Moynihan, TJ, Vahdat, LT, Goetz, MP, Beumer, JH, Hurria, A, Mortimer, J, Piekarz, R, Sand, S, Herzog, J, Van Tongeren, LR, Ferry-Galow, KV, Chen, AP, Ruel, C, Newman, EM, Gandara, DR & Weitzel, JN 2017, 'Efficacy of the PARP inhibitor veliparib with carboplatin or as a single agent in patients with germline BRCA1- or BRCA2-associated metastatic breast cancer: California Cancer Consortium trial NCT01149083', Clinical Cancer Research, vol. 23, no. 15, pp. 4066-4076. https://doi.org/10.1158/1078-0432.CCR-16-2714
Jia, H, Truica, C, Wang, B, Wang, Y, Ren, X, Harvey, H, Song, J & Yang, J-M 2017, 'Immunotherapy for triple-negative breast cancer: Existing challenges and exciting prospects', Drug Resistance Updates, vol. 32, pp. 1-15. https://doi.org/10.1016/j.drup.2017.07.002
Yin, M, Wang, W, Drabick, J & Harvey, H 2017, 'Prognosis and treatment of non-metastatic primary and secondary breast angiosarcoma: A comparative study', BMC Cancer, vol. 17, no. 1, 295. https://doi.org/10.1186/s12885-017-3292-7

2016

Cheng, Y, Ren, X, Yuan, Y, Shan, Y, Li, L, Chen, X, Zhang, L, Takahashi, Y, Yang, JW, Han, B, Liao, JJ, Li, Y, Harvey, H, Ryazanov, A, Robertson, G, Wan, G, Liu, D, Chen, AF, Tao, Y & Yang, J-M 2016, 'EEF-2 kinase is a critical regulator of Warburg effect through controlling PP2A-A synthesis', Oncogene, vol. 35, no. 49, pp. 6293-6308. https://doi.org/10.1038/onc.2016.166
Yin, M, Joshi, M, Meijer, RP, Glantz, M, Holder, S, Harvey, H, Kaag, MG, Van De Putte, EEF, Horenblas, S & Drabick, J 2016, 'Neoadjuvant chemotherapy for muscle-invasive bladder cancer: A systematic review and two-step meta-analysis', Oncologist, vol. 21, no. 6, pp. 708-715. https://doi.org/10.1634/theoncologist.2015-0440
Yin, M, MacKley, HB, Drabick, JJ & Harvey, HA 2016, 'Primary female breast sarcoma: Clinicopathological features, treatment and prognosis', Scientific reports, vol. 6, 31497. https://doi.org/10.1038/srep31497

2015

Al-Marrawi, MY, Cream, L, Mallon, CA, Holder, S, Joshi, M, Harvey, H, Talamo, G & Drabick, J 2015, 'Effect of topical vaginal androgens in a woman on the testosterone levels of her sexual partner with prostate cancer', Journal of Clinical Oncology, vol. 33, no. 5, pp. 521-522. https://doi.org/10.1200/JCO.2014.59.7773
El-Deiry, WS, Vijayvergia, N, Xiu, J, Scicchitano, A, Lim, B, Yee, NS-S, Harvey, H, Gatalica, Z & Reddy, S 2015, 'Molecular profiling of 6,892 colorectal cancer samples suggests different possible treatment options specific to metastatic sites', Cancer Biology and Therapy, vol. 16, no. 12, pp. 1726-1737. https://doi.org/10.1080/15384047.2015.1113356

Clinical Trials Search


Children (age < 18 years)
Adults (age >= 18 years)